N-[2-(2-oxoimidazolidin-1-yl)ethyl]-2-[[(2S)-2-phenyl-3,4-dihydro-2H-chromen-6-yl]oxy]-1,3-thiazole-4-carboxamide

C24H24N4O4S — CID 91754898

IUPACN-[2-(2-oxoimidazolidin-1-yl)ethyl]-2-[[(2S)-2-phenyl-3,4-dihydro-2H-chromen-6-yl]oxy]-1,3-thiazole-4-carboxamide
SMILESO=C(NCCN1CCNC1=O)c1csc(Oc2ccc3c(c2)CC[C@@H](c2ccccc2)O3)n1
InChIInChI=1S/C24H24N4O4S/c29-22(25-10-12-28-13-11-26-23(28)30)19-15-33-24(27-19)31-18-7-9-21-17(14-18)6-8-20(32-21)16-4-2-1-3-5-16/h1-5,7,9,14-15,20H,6,8,10-13H2,(H,25,29)(H,26,30)/t20-/m0/s1
InChIKeyQORWKSQIFABYNQ-FQEVSTJZSA-N
MW464.55 g/mol
LogP3.76
Rot. Bonds7

About N-[2-(2-oxoimidazolidin-1-yl)ethyl]-2-[[(2S)-2-phenyl-3,4-dihydro-2H-chromen-6-yl]oxy]-1,3-thiazole-4-carboxamide

N-[2-(2-oxoimidazolidin-1-yl)ethyl]-2-[[(2S)-2-phenyl-3,4-dihydro-2H-chromen-6-yl]oxy]-1,3-thiazole-4-carboxamide (PubChem CID 91754898) has the molecular formula C24H24N4O4S and a molecular weight of 464.55 g/mol. Its IUPAC name is N-[2-(2-oxoimidazolidin-1-yl)ethyl]-2-[[(2S)-2-phenyl-3,4-dihydro-2H-chromen-6-yl]oxy]-1,3-thiazole-4-carboxamide.

Molecular Properties

Compound NameN-[2-(2-oxoimidazolidin-1-yl)ethyl]-2-[[(2S)-2-phenyl-3,4-dihydro-2H-chromen-6-yl]oxy]-1,3-thiazole-4-carboxamide
PubChem CID91754898
Molecular FormulaC24H24N4O4S
Molecular Weight464.55 g/mol
Exact Mass464.15
IUPAC NameN-[2-(2-oxoimidazolidin-1-yl)ethyl]-2-[[(2S)-2-phenyl-3,4-dihydro-2H-chromen-6-yl]oxy]-1,3-thiazole-4-carboxamide
SMILESO=C(NCCN1CCNC1=O)c1csc(Oc2ccc3c(c2)CC[C@@H](c2ccccc2)O3)n1
InChIInChI=1S/C24H24N4O4S/c29-22(25-10-12-28-13-11-26-23(28)30)19-15-33-24(27-19)31-18-7-9-21-17(14-18)6-8-20(32-21)16-4-2-1-3-5-16/h1-5,7,9,14-15,20H,6,8,10-13H2,(H,25,29)(H,26,30)/t20-/m0/s1
InChIKeyQORWKSQIFABYNQ-FQEVSTJZSA-N
XLogP3.76
TPSA92.79 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms33
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500464.55
LogP ≤ 53.76
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze N-[2-(2-oxoimidazolidin-1-yl)ethyl]-2-[[(2S)-2-phenyl-3,4-dihydro-2H-chromen-6-yl]oxy]-1,3-thiazole-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-(2-oxoimidazolidin-1-yl)ethyl]-2-[[(2S)-2-phenyl-3,4-dihydro-2H-chromen-6-yl]oxy]-1,3-thiazole-4-carboxamide?
The IUPAC name of N-[2-(2-oxoimidazolidin-1-yl)ethyl]-2-[[(2S)-2-phenyl-3,4-dihydro-2H-chromen-6-yl]oxy]-1,3-thiazole-4-carboxamide (CID 91754898) is N-[2-(2-oxoimidazolidin-1-yl)ethyl]-2-[[(2S)-2-phenyl-3,4-dihydro-2H-chromen-6-yl]oxy]-1,3-thiazole-4-carboxamide.
What is the SMILES notation for N-[2-(2-oxoimidazolidin-1-yl)ethyl]-2-[[(2S)-2-phenyl-3,4-dihydro-2H-chromen-6-yl]oxy]-1,3-thiazole-4-carboxamide?
The canonical SMILES for N-[2-(2-oxoimidazolidin-1-yl)ethyl]-2-[[(2S)-2-phenyl-3,4-dihydro-2H-chromen-6-yl]oxy]-1,3-thiazole-4-carboxamide is O=C(NCCN1CCNC1=O)c1csc(Oc2ccc3c(c2)CC[C@@H](c2ccccc2)O3)n1.
What is the InChIKey of N-[2-(2-oxoimidazolidin-1-yl)ethyl]-2-[[(2S)-2-phenyl-3,4-dihydro-2H-chromen-6-yl]oxy]-1,3-thiazole-4-carboxamide?
The InChIKey is QORWKSQIFABYNQ-FQEVSTJZSA-N. The full InChI is InChI=1S/C24H24N4O4S/c29-22(25-10-12-28-13-11-26-23(28)30)19-15-33-24(27-19)31-18-7-9-21-17(14-18)6-8-20(32-21)16-4-2-1-3-5-16/h1-5,7,9,14-15,20H,6,8,10-13H2,(H,25,29)(H,26,30)/t20-/m0/s1.
What are the key properties of N-[2-(2-oxoimidazolidin-1-yl)ethyl]-2-[[(2S)-2-phenyl-3,4-dihydro-2H-chromen-6-yl]oxy]-1,3-thiazole-4-carboxamide?
N-[2-(2-oxoimidazolidin-1-yl)ethyl]-2-[[(2S)-2-phenyl-3,4-dihydro-2H-chromen-6-yl]oxy]-1,3-thiazole-4-carboxamide has a molecular weight of 464.55 g/mol, XLogP of 3.76, 7 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(2-oxoimidazolidin-1-yl)ethyl]-2-[[(2S)-2-phenyl-3,4-dihydro-2H-chromen-6-yl]oxy]-1,3-thiazole-4-carboxamide is sourced from PubChem (CID 91754898), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).